Meeder Asset Management Inc Precigen, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.53 - $5.5 $22,161 - $34,529	-6,278 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$4.99 - $6.55 $3,028 - $3,975	-607 Reduced 8.82%	6,278 $30,000
Q2 2021 Aug 09, 2021	BUY	$6.24 - $8.22 $24,654 - $32,477	3,951 Added 134.66%	6,885 $45,000
Q1 2021 Apr 28, 2021	BUY	$6.74 - $10.95 $19,775 - $32,127	2,934 New	2,934 $21,000
Q4 2020 Feb 09, 2021	SELL	$3.75 - $10.56 $18,090 - $50,941	-4,824 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$3.5 - $6.2 $14,007 - $24,812	-4,002 Reduced 45.34%	4,824 $15,000
Q2 2020 Aug 11, 2020	BUY	$2.16 - $5.46 $18,070 - $45,678	8,366 Added 1818.7%	8,826 $44,000
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $671 - $3,307	460 New	460 $2,000

141

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $231M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.